Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Production of
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
) by murine tumors has been shown to induce immune suppressive cells having homology with GM progenitor cells. The purpose of this study was to determine if human head and neck cancers secrete
GM-CSF
, if this is associated with an intratumoral presence of similar cells expressing the
hematopoietic progenitor cell antigen CD34
, and if such CD34(+) cells suppress functions of intratumoral T cells. This was evaluated with fresh head and neck cancers, and in some instances regional lymph nodes and control tissue. Ten of the 14 squamous cell carcinomas (SCCs) studied secreted greater than 5 ng
GM-CSF
/g tissue.
GM-CSF
was not secreted in significant levels by either the other cancer types or by control normal muscle. Each of the high
GM-CSF
-secreting SCCs, but none of the cancers that did not secrete
GM-CSF
, contained cells expressing the
hematopoietic progenitor cell antigen CD34
that had the capacity to grow into colonies in soft agar. Available regional lymph nodes from patients with high
GM-CSF
-producing cancers also contained CD34(+) cells. Depletion of CD34(+) cells from dissociated cancers increased interleukin 2 secretion by the intratumoral lymphocytes while addition of the CD34(+) cells to dissociated cancers reduced interleukin 2 production, indicating that the presence of CD34(+) cells within
GM-CSF
-producing head and neck SCCs results in suppressed functional competence of lymphocytes within the SCCs. These results show that
GM-CSF
-secreting SCCs contain cells expressing the hematopoietic antigen CD34 which are inhibitory to the capacity of lymphocytes within the SCCs to secrete interleukin 2.
...
PMID:Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. 981 91